During the past decade, Hospital Universitario Infanta Cristina conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 6 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Infanta Cristina" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "PETHEMA Foundation" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Spanish Breast Cancer Research Group" with 2 trials sponsored and "Spanish Lung Cancer Group" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Infanta Cristina" #1 collaborator was "Celgene" with 2 trials as a collaborator, "Hospital Universitario 12 de Octubre" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Hospital Arnau de Vilanova" with 1 trials as a collaborator and "Janssen, LP" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Infanta Cristina" are "Breast Cancer" (2 trials), "Carcinoma, Renal Cell" (2 trials), "Metastatic Breast Cancer" (2 trials), "Multiple Myeloma" (2 trials) and "Acute Respiratory Failure" (1 trials). Many other conditions were trialed in "Hospital Universitario Infanta Cristina" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Infanta Cristina" are "Drug" (13 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Neratinib" (2 trials), "Paclitaxel" (2 trials), "Placebo" (2 trials), "Trastuzumab" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Infanta Cristina" are 14 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Infanta Cristina". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Hospital Universitario Infanta Cristina, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Infanta Cristina, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".